Article citationsMore>>

Chung, M.W., Kim, M.J., Won, E.J., et al. (2021) Gut Microbiome Composition Can Predict the Response to Nivolumab in Advanced Hepatocellular Carcinoma Patients. World Journal of Gastroenterology, 27, 7340-7349.
https://doi.org/10.3748/wjg.v27.i42.7340

has been cited by the following article:

• TITLE: Study of Immunotherapy and Intestinal Flora Changes in Patients with Liver Cancer

  AUTHORS: Junhao Lin, Yong Li

  KEYWORDS: Hepatocellular Carcinoma, Intestinal Flora, Immunotherapy, Overview

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.11 No.2, February 27, 2023

  ABSTRACT: Hepatocellular carcinoma (HCC) is one of the common major malignancies worldwide and has the third highest mortality rate of any malignancy. The current field of treatment for hepatocellular carcinoma is multidisciplinary in involvement and a combination of therapeutic approaches, among which immunotherapy is the treatment modality for advanced hepatocellular carcinoma. This review provides new ideas for developing immunotherapy regimens and improving the efficacy of immunotherapy for patients with advanced liver cancer by summarising the progress of intestinal flora in the immunotherapy of patients with liver cancer.